CLBR Per Initial Cycle With Different Starting Dose in Aged Patients With Poor Ovarian Reservation: 300IU Versus 150IU

• Status: Recruiting
• Trial end date: 2021-04-30
• Target enrollment: 0
• Participant gender: Female

Summary

Among aged patients with poor ovarian reservation(defined as age 35 to 42 years; antral follicle count（AFC）≤ 5 or anti-mullerian hormone（AMH）≤ 1.2 ng/ml), cumulative live birth rate(CLBR) and time to live birth(TTLB) of the first stimulation cycle were compared between a starting dose of 300IU or 150IU rFSH in controlled ovarian stimulation with gonadotropin-releasing hormone（GnRH）antagonist protocol. This study is a prospective randomized controlled trial.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Reproductive & Genetic Hospital of CITIC-Xiangya

Criteria

Inclusion Criteria:

1. Age Limits≥35 and≤42；

2. AFC≤5 or AMH≤1.2ng/ml；

3. BMI≤30kg/m2；

4. The first IVF/intracytoplasmic sperm injection （ICSI） cycle；

Exclusion Criteria:

1. Any other underlying disease or condition considered IVF is contraindicated.

2. Ovarian hyperstimulation syndrome（PCOS）, moderate or severe intrauterine adhesion，untreated hydrosalpinx, adenomyosis， any myoma in cases that endometrium was affected, intramural larger than 4cm.

3. Autoimmune antibody positive, untreated.

4. History of recurrent miscarriages.

5. Patients seeking for Preimplantation Genetic Testing(PGT) treatment.

6. Simultaneous participation in another clinical study.

7. According to the judgment of the investigator, any reason or condition that precludes subject for participating in the study.